Geode Capital Management’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
265,324
+1,600
| +0.6% | +$12.2K | ﹤0.01% | 3137 |
|
|
2025
Q1 | $860K | Buy |
263,724
+8,488
| +3% | +$27.7K | ﹤0.01% | 3355 |
|
|
2024
Q4 | $1.15M | Buy |
255,236
+2,938
| +1% | +$13.2K | ﹤0.01% | 3323 |
|
|
2024
Q3 | $699K | Buy |
252,298
+91,246
| +57% | +$253K | ﹤0.01% | 3479 |
|
|
2024
Q2 | $551K | Sell |
161,052
-238,747
| -60% | -$817K | ﹤0.01% | 3535 |
|
|
2024
Q1 | $2.17M | Buy |
399,799
+279,023
| +231% | +$1.51M | ﹤0.01% | 3085 |
|
|
2023
Q4 | $655K | Buy |
120,776
+10,075
| +9% | +$54.6K | ﹤0.01% | 3513 |
|
|
2023
Q3 | $974K | Buy |
+110,701
| New | +$974K | ﹤0.01% | 3331 |
|